Clinical Outcomes of Single Anteromedial Bundle Biologic Augmentation Technique for Anterior Cruciate Ligament Reconstruction With Consideration of Tibial Remnant Size

Ouanezar, Hervé; Blakeney, William G.; Fernandes, Levi Reina; Borade, Amrut; Latrobe, Charles; Temponi, Eduardo Frois; Sonnery‐Cottet, Bertrand

doi:10.1016/j.arthro.2017.08.309

Cited by 33 publications

(40 citation statements)

References 48 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

Section: Resultsmentioning

confidence: 99%

“…34 The incidence of cyclops lesion after single anteromedial bundle biological augmentation ACLR technique (a type of remnant-preserving technique) was found to be 3.7% (5/135 cases). 26 A greater incidence of cyclops lesion in female patients, as high as 4 times greater than that in their male counterparts, has been reported by various studies. 24,27 A greater incidence has also been reported after bicruciate-retaining total knee arthroplasty 18,42 even without injury to the ACL.…”

Section: Etiological Factorsmentioning

confidence: 92%

See 1 more Smart Citation

Cyclops Lesions of the Knee: A Narrative Review of the Literature

Kambhampati¹,

Gollamudi

Shanmugasundaram³

et al. 2020

Orthopaedic Journal of Sports Medicine

View full text Add to dashboard Cite

Cyclops lesion is a known complication of anterior cruciate ligament reconstruction (ACLR). Although the incidence of cyclops lesion appears to be decreasing, it remains an important cause of restriction of extension after ACLR. We reviewed the available literature regarding the cyclops lesion and syndrome and cyclops-like lesions to analyze available evidence on cyclops lesions and variants of cyclops lesions. A keyword search in PubMed, Scopus, Web of Science, and EMBASE, Ovid Medline, and Ovid journals provided 47 relevant articles in the English literature, which were used to create this review. We classified cyclops lesions based on clinical presentation, pathology, and location. Risk factors, management options, tips to reduce the condition, and controversies related to the condition have been discussed. Female sex, greater graft volume, bony avulsion injuries, excessively anterior tibial tunnel, double-bundle ACLR, and bicruciate-retaining arthroplasty appear to predispose patients to cyclops lesions. Cyclops syndrome is a cyclops lesion that causes a loss of terminal extension. Arthroscopic debridement is an effective treatment for cyclops syndrome, whereas cyclops lesions are usually managed conservatively. It is important to distinguish between cyclops lesion and cyclops syndrome, as management differs based on symptoms. Cyclops lesion is diagnosed using magnetic resonance imaging. The management of choice for symptomatic lesions is surgical excision. Outcomes after excision are very good, and recurrence is rare.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Etiological Factorsmentioning

confidence: 92%

Cyclops Lesions of the Knee: A Narrative Review of the Literature

Kambhampati¹,

Gollamudi

Shanmugasundaram³

et al. 2020

Orthopaedic Journal of Sports Medicine

View full text Add to dashboard Cite

show abstract

“…However, failure rates with conversion to TKA were 33% to 35% within 2.5 years. 3,10,32,39 Although the . No patient experienced any AE more than once.…”

Section: Discussionmentioning

confidence: 99%

“…However, failure rates with conversion to TKA were 33% to 35% within 2.5 years. 3 , 10 , 32 , 39 Although the UniSpacer and NUsurface are both single-component, unicondylar, self-centering devices for the medial compartment, key differences exist. First, the soft material nature of the polymeric composition of NUsurface mimics the properties of the native meniscus, enabling high conformity and distributed contact pressures 27 compared with those of the rigid, metal construction of the UniSpacer.…”

Section: Discussionmentioning

confidence: 99%

Preliminary Results From a US Clinical Trial of a Novel Synthetic Polymer Meniscal Implant

McKeon

Zaslav

Alfred

et al. 2020

Orthopaedic Journal of Sports Medicine

View full text Add to dashboard Cite

Background: At least 760,000 outpatient meniscectomies are performed in the United States each year, making this the most common musculoskeletal procedure. However, meniscal resection can alter the joint biomechanics and overload the articular cartilage, which may contribute to degenerative changes and the need for knee replacement. Avoiding or delaying knee replacement is particularly important in younger or more active patients. Synthetic meniscal implants have been developed in an attempt to restore the natural joint biomechanics, alleviate pain and disability, and potentially minimize degenerative changes in patients who require meniscectomy. Purpose To evaluate the preliminary results from 2 ongoing trials that are evaluating the safety and effectiveness of a synthetic polymer meniscal implant (NUsurface; Active Implants, LLC). Study Design: Cohort study; Level of evidence, 2. Methods: This was a preliminary analysis of the first 100 patients enrolled across 2 studies for 12 months: a single-arm, intervention-only study and a randomized controlled trial comparing the investigational meniscal implant with nonsurgical therapy. There were 65 patients in the implant group (30 randomized) and 35 in the control group. Outcomes included Knee injury and Osteoarthritis Outcome Score (KOOS) and adverse events (AEs) collected at baseline and follow-up visits of 6 weeks, 6 months, and 12 months. Results: No statistically significant differences were found in baseline characteristics between the implant and control groups. At 12 months, follow-up KOOS data were available for 87% of the 100 included patients. Significantly greater improvements from baseline were observed in the implant group compared with controls in all KOOS subcomponents, except for symptoms (119%-177% greater improvement at 12 months). AEs were reported at similar rates between the 2 groups, with 12 AEs among 11 patients in the implant group (16.9%) versus 5 AEs among 5 patients (14.3%) in the control group ( P = .99). Conclusion: These preliminary results suggest significant improvements in pain and function scores with the implant over nonsurgical therapy and a similar adverse event rate.

show abstract

“…Without effective treatment, ACL rupture could develop osteoarthritis of knee in future. Numerous studies in recent years have reported excellent outcomes in patients undergoing ACL reconstruction [ 17 , 19 , 20 ]. However, it is a major concern that failure rate of ACL reconstruction was reported from 1.4% to 18% [ 21 – 24 ].…”

Section: Discussionmentioning

confidence: 99%

Do Nonsteroidal Anti-Inflammatory Drugs Affect Tissue Healing After Arthroscopic Anterior Cruciate Ligament Reconstruction?

Liu

Shrestha³

et al. 2018

Med Sci Monit

View full text Add to dashboard Cite

BackgroundExperimental studies have reported nonsteroidal anti-inflammatory drugs (NSAIDs) could impair tendon healing. The purpose of this study was to investigate whether NSAIDs could affect recovery of knee joint function in patients after anterior cruciate ligament (ACL) reconstruction.Material/MethodsWe enrolled 40 patients treated with celecoxib and 40 patients treated with tramadol, who underwent ACL reconstruction from January 2011 to December 2017. Visual analogue scale (VAS) and functional outcomes were collected and evaluated. The follow-up period was 12 months.ResultsIn both groups, all patients obtained pain release after surgery, compared with that before surgery. But no significant differences were observed between the 2 groups in VAS scores. We also did not find any differences between the 2 groups at 1 year of follow-up, in terms of anterior drawer test, Lachman test, side-to-side laxity assessed by KT-2000, IKDC score, Lysholm score, and Tegner scale. However, the celecoxib group showed a reduced incidence of nausea compared to the tramadol group (P=0.048).ConclusionsThe use of NSAIDs after ACL reconstruction is relatively safe and could decrease adverse side effects which were caused by opioid drugs.

show abstract

Clinical Outcomes of Single Anteromedial Bundle Biologic Augmentation Technique for Anterior Cruciate Ligament Reconstruction With Consideration of Tibial Remnant Size

Cited by 33 publications

References 48 publications

Cyclops Lesions of the Knee: A Narrative Review of the Literature

Cyclops Lesions of the Knee: A Narrative Review of the Literature

Preliminary Results From a US Clinical Trial of a Novel Synthetic Polymer Meniscal Implant

Do Nonsteroidal Anti-Inflammatory Drugs Affect Tissue Healing After Arthroscopic Anterior Cruciate Ligament Reconstruction?

Contact Info

Product

Resources

About